New Market Research Report: Poland Pharmaceuticals & Healthcare Report Q4 2013
BMI View: Plans to roll over reserves from pharmaceutical expenditure to cover NFZ deficits are not longterm solutions to the chronic underfunding of the Polish healthcare system. While the NFZ has made savings on medicine reimbursements, it is Polish patients who have borne the cost of those spending cuts. With Polish citizens already spending a significant proportion of their income on healthcare, we believe that provisions for private health insurance to bridge gaps in coverage should be rolled out rapidly.
View full press release